First publication from South Africa and first stem cell transplantation performed in Mexico
Just over a year after Glycosorb® ABO was used for the first time in South Africa and on the African continent, the initial experience with our product in blood group incompatible kidney transplantation has been published[1]. The results are excellent. In February 2023, the transplant team at Groote Schuur Hospital in Cape Town, as the first hospital on the African continent, performed an ABO-incompatible kidney transplant treating a mother of two, who had been on the waiting list for nearly 10 years, with Glycosorb® ABO. The treatments and the transplant were successfully performed and